Literature DB >> 8042323

Total shunting and elective management of variceal bleeding.

S Stipa1, G Balducci, V Ziparo, F Stipa, G Lucandri.   

Abstract

A 20-year experience with treatment of esophageal varices in patients with cirrhosis is reported. Considering that total shunts are well tolerated immediately after operation (hospital mortality rate for all elective procedures being 6.4%), that they offer a good protection against rebleeding (rebleeding variceal rate of 7.6%), and that they offer the same long-term survival as given by other shunts (5- and 10-year survival rates of 57% and 31%, respectively), the authors affirm that these kinds of shunts are still useful in well selected cases. Late follow-up results of a prospective randomized trial of elective mesocaval shunts compared to portacaval shunt have shown no significant differences in operative mortality, rebleeding rates, encephalopathy rates, or survival. Based on this information, the authors currently use portacaval shunt as their operation of choice.

Entities:  

Mesh:

Year:  1994        PMID: 8042323     DOI: 10.1007/bf00294401

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  24 in total

Review 1.  The Emory perspective of the distal splenorenal shunt in 1990.

Authors:  J M Henderson; W J Millikan; J R Galloway
Journal:  Am J Surg       Date:  1990-07       Impact factor: 2.565

2.  Portasystemic shunting procedures for portal hypertension. Twenty-six year experience in adults with cirrhosis of the liver.

Authors:  A B Voorhees; J B Price; R C Britton
Journal:  Am J Surg       Date:  1970-05       Impact factor: 2.565

3.  Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding.

Authors:  H A Harley; T Morgan; A G Redeker; T B Reynolds; F Villamil; J M Weiner; A Yellin
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

4.  Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial.

Authors:  G P Spina; R Santambrogio; E Opocher; F Cosentino; A Zambelli; G R Passoni; G Cucchiaro; M Macrì; E Morandi; S Bruno
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

5.  Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  R Planas; J Boix; M Broggi; E Cabré; M C Gomes-Vieira; R Morillas; M Armengol; R De León; P Humbert; J A Salvá
Journal:  Gastroenterology       Date:  1991-04       Impact factor: 22.682

6.  The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up.

Authors:  W J Millikan; W D Warren; J M Henderson; R B Smith; A A Salam; J T Galambos; M H Kutner; J H Keen
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

7.  Surgical procedures for bleeding esophagogastric varices when sclerotherapy fails: a prospective study.

Authors:  K J Paquet; M A Mercado; H A Gad
Journal:  Am J Surg       Date:  1990-07       Impact factor: 2.565

8.  Comparison of distal and proximal splenorenal shunts: a randomized prospective trial.

Authors:  J E Fischer; R H Bower; S Atamian; R Welling
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

9.  Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life.

Authors:  B Langer; B R Taylor; D R Mackenzie; T Gilas; R M Stone; L Blendis
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

Review 10.  Management of esophageal varices in the Western world--the state of the art.

Authors:  S Stipa; V Ziparo; E Di Giulio; G Balducci
Journal:  Jpn J Surg       Date:  1989-03
View more
  1 in total

1.  An attempt to decrease ammonia levels after portacaval anastomosis in dogs: hepatic periarterial neurectomy.

Authors:  Sezai Yilmaz; Vedat Kirimlioglu; Daniel Katz; Kayhan Basak; Mehmet Caglikulekci; Cuneyt Kayaalp; Bulent Yildirim; Musa Akoglu
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.